Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-05

AUTHORS

C Anthias, F L Dignan, R Morilla, A Morilla, M E Ethell, M N Potter, B E Shaw

ABSTRACT

The presence of minimal residual disease (MRD) by multiparametric flow cytometry (MFC) has been associated with adverse outcomes in AML patients treated with chemotherapy alone, but its impact in the setting of allogeneic hematopoietic SCT (HSCT) is less clear. We studied 88 patients who underwent myeloablative (MA) or reduced-intensity conditioned allogeneic HSCT for AML in first or subsequent remission at our center. MRD status was determined using three-color MFC on pre-HSCT BM aspirates, and patients were stratified by MRD status into MRD-negative, low-level MRD-positive (<1%) or high-level MRD-positive groups (1-4.9%). Two-year survival estimates in these groups were 66.8%, 51% and 30%, respectively (P=0.012), and 2-year estimates of relapse were 7.6, 37 and 70% (P<0.001). Pre-HSCT MRD was related to disease characteristics including secondary AML (P=0.002) and primary induction failure (P=0.005), but, despite these strong correlations, MRD remained independently associated with poorer survival in multivariate analysis (hazard ratio, 1.92; P=0.014). Pre-HSCT MRD is associated with adverse clinical outcomes in AML patients undergoing reduced-intensity or MA HSCT in first or subsequent remission and should be integrated into transplant strategies for patients with AML. More... »

PAGES

679

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2014.9

DOI

http://dx.doi.org/10.1038/bmt.2014.9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021248967

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24510069


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myeloablative Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm, Residual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Royal Marsden Hospital", 
          "id": "https://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anthias", 
        "givenName": "C", 
        "id": "sg:person.01353611054.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353611054.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden Hospital", 
          "id": "https://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dignan", 
        "givenName": "F L", 
        "id": "sg:person.0631553145.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631553145.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK", 
            "The Institute of Cancer Research, Sutton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morilla", 
        "givenName": "R", 
        "id": "sg:person.01010661144.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010661144.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK", 
            "The Institute of Cancer Research, Sutton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morilla", 
        "givenName": "A", 
        "id": "sg:person.01021756561.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021756561.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden Hospital", 
          "id": "https://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ethell", 
        "givenName": "M E", 
        "id": "sg:person.01053700261.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053700261.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden Hospital", 
          "id": "https://www.grid.ac/institutes/grid.424926.f", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Potter", 
        "givenName": "M N", 
        "id": "sg:person.016310433302.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016310433302.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Anthony Nolan", 
          "id": "https://www.grid.ac/institutes/grid.426412.7", 
          "name": [
            "Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK", 
            "Anthony Nolan, UCL Cancer Centre, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shaw", 
        "givenName": "B E", 
        "id": "sg:person.0727054455.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727054455.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.beha.2010.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007698899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2013-06-506725", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007787544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.22.4865", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008077664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2012.04.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008549363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2010.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012262959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa074306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013947506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.15.9814", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016398724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa041974", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020502159"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2011.02.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021789580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-11-254441", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021909700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-06-025627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022105086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2009.813", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022940233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-03-1036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024111969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2013.124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027049780", 
          "https://doi.org/10.1038/bmt.2013.124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-08-363291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028166821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029511634", 
          "https://doi.org/10.1038/sj.leu.2404313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029511634", 
          "https://doi.org/10.1038/sj.leu.2404313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428194.2010.500431", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037021077"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-03-0880", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038155124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-209262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038343487"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajh.21340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040068744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1309/fy0umamm91vpmr2w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042362593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-09-047225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047732589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.31.8121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049240685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.beha.2007.11.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052238191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-12-3714", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052289115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074731728", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075299915", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077254470", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083152211", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05", 
    "datePublishedReg": "2014-05-01", 
    "description": "The presence of minimal residual disease (MRD) by multiparametric flow cytometry (MFC) has been associated with adverse outcomes in AML patients treated with chemotherapy alone, but its impact in the setting of allogeneic hematopoietic SCT (HSCT) is less clear. We studied 88 patients who underwent myeloablative (MA) or reduced-intensity conditioned allogeneic HSCT for AML in first or subsequent remission at our center. MRD status was determined using three-color MFC on pre-HSCT BM aspirates, and patients were stratified by MRD status into MRD-negative, low-level MRD-positive (<1%) or high-level MRD-positive groups (1-4.9%). Two-year survival estimates in these groups were 66.8%, 51% and 30%, respectively (P=0.012), and 2-year estimates of relapse were 7.6, 37 and 70% (P<0.001). Pre-HSCT MRD was related to disease characteristics including secondary AML (P=0.002) and primary induction failure (P=0.005), but, despite these strong correlations, MRD remained independently associated with poorer survival in multivariate analysis (hazard ratio, 1.92; P=0.014). Pre-HSCT MRD is associated with adverse clinical outcomes in AML patients undergoing reduced-intensity or MA HSCT in first or subsequent remission and should be integrated into transplant strategies for patients with AML. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bmt.2014.9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "49"
      }
    ], 
    "name": "Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML", 
    "pagination": "679", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "653daf93d7b489cde842bcf283840856fa458795315f8ead1ce13081f11547a5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24510069"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2014.9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021248967"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2014.9", 
      "https://app.dimensions.ai/details/publication/pub.1021248967"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000436.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bmt20149"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2014.9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2014.9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2014.9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2014.9'


 

This table displays all metadata directly associated to this object as RDF triples.

280 TRIPLES      21 PREDICATES      77 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2014.9 schema:about N063f4fb59c534f12aa743131cb87ff19
2 N1084cc8cb1fa43b6bf21540dab86b6f1
3 N12098e38e7be4ba9b483ba5a688b7478
4 N15a64546d9444081b49d83fc549869d3
5 N193150b30cab4fcb8640e4261773be00
6 N1dcd9a3f474a4e69ac15a0a9795ece5c
7 N26deaa7ac40f421391232d50497b64a6
8 N2be7220926414b8fb751e0d15a16c151
9 N33c9bb4a1d1b4dadabe950b5d2aab22d
10 N4964c0a51553463a884e4fa0584cc806
11 N5680e6e766164bd8b794e5d544d22ef9
12 N6eb32afbb3c94ee6999a515e3b2d8916
13 N71b31573eb374789aba2d42c13b6a325
14 N7c5d93be7116448dab4f1916f5a38242
15 N99432cfa2ade480b8f9eece3863f710f
16 Na7a840a2ba664f8b8140c99b25b803f9
17 Naaad1f5352c84642bd470e17681bede6
18 Nbc49eb18397446de856ba5a570a2d18a
19 Nc2a723dff229452da27b764940d9c841
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N5fc336598bc24cfb984868be29b984e1
23 schema:citation sg:pub.10.1038/bmt.2013.124
24 sg:pub.10.1038/sj.leu.2404313
25 https://app.dimensions.ai/details/publication/pub.1074731728
26 https://app.dimensions.ai/details/publication/pub.1075299915
27 https://app.dimensions.ai/details/publication/pub.1077254470
28 https://app.dimensions.ai/details/publication/pub.1083152211
29 https://doi.org/10.1001/jama.2009.813
30 https://doi.org/10.1002/ajh.21340
31 https://doi.org/10.1016/j.bbmt.2011.02.003
32 https://doi.org/10.1016/j.beha.2007.11.013
33 https://doi.org/10.1016/j.beha.2010.06.007
34 https://doi.org/10.1016/j.leukres.2010.12.013
35 https://doi.org/10.1016/j.leukres.2012.04.005
36 https://doi.org/10.1056/nejmoa041974
37 https://doi.org/10.1056/nejmoa074306
38 https://doi.org/10.1182/blood-2002-12-3714
39 https://doi.org/10.1182/blood-2003-03-0880
40 https://doi.org/10.1182/blood-2004-03-1036
41 https://doi.org/10.1182/blood-2006-06-025627
42 https://doi.org/10.1182/blood-2006-09-047225
43 https://doi.org/10.1182/blood-2009-03-209262
44 https://doi.org/10.1182/blood-2009-11-254441
45 https://doi.org/10.1182/blood-2011-08-363291
46 https://doi.org/10.1182/blood-2013-06-506725
47 https://doi.org/10.1200/jco.2007.15.9814
48 https://doi.org/10.1200/jco.2009.22.4865
49 https://doi.org/10.1200/jco.2010.31.8121
50 https://doi.org/10.1309/fy0umamm91vpmr2w
51 https://doi.org/10.3109/10428194.2010.500431
52 schema:datePublished 2014-05
53 schema:datePublishedReg 2014-05-01
54 schema:description The presence of minimal residual disease (MRD) by multiparametric flow cytometry (MFC) has been associated with adverse outcomes in AML patients treated with chemotherapy alone, but its impact in the setting of allogeneic hematopoietic SCT (HSCT) is less clear. We studied 88 patients who underwent myeloablative (MA) or reduced-intensity conditioned allogeneic HSCT for AML in first or subsequent remission at our center. MRD status was determined using three-color MFC on pre-HSCT BM aspirates, and patients were stratified by MRD status into MRD-negative, low-level MRD-positive (<1%) or high-level MRD-positive groups (1-4.9%). Two-year survival estimates in these groups were 66.8%, 51% and 30%, respectively (P=0.012), and 2-year estimates of relapse were 7.6, 37 and 70% (P<0.001). Pre-HSCT MRD was related to disease characteristics including secondary AML (P=0.002) and primary induction failure (P=0.005), but, despite these strong correlations, MRD remained independently associated with poorer survival in multivariate analysis (hazard ratio, 1.92; P=0.014). Pre-HSCT MRD is associated with adverse clinical outcomes in AML patients undergoing reduced-intensity or MA HSCT in first or subsequent remission and should be integrated into transplant strategies for patients with AML.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf N04db603b38f647a28634fbe89bb2a7b7
59 Nd97093a55cee4dfe83d9b1235043eeec
60 sg:journal.1096890
61 schema:name Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML
62 schema:pagination 679
63 schema:productId N0732ff0324aa457d8323f52b63bb9b7f
64 N0f2d1fc039224f5dbadc90aa429b4a32
65 Nc83c9063112c454a9eaef0df8c3766ca
66 Ne1833f751c764474b72f1a50dc0910fe
67 Nf1b324bd10c04f8f8bfb11274dc29c74
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021248967
69 https://doi.org/10.1038/bmt.2014.9
70 schema:sdDatePublished 2019-04-10T19:46
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher Nce8c661db47c4ee4b336b12f4a5527d6
73 schema:url https://www.nature.com/articles/bmt20149
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N04db603b38f647a28634fbe89bb2a7b7 schema:issueNumber 5
78 rdf:type schema:PublicationIssue
79 N063f4fb59c534f12aa743131cb87ff19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Prognosis
81 rdf:type schema:DefinedTerm
82 N0732ff0324aa457d8323f52b63bb9b7f schema:name readcube_id
83 schema:value 653daf93d7b489cde842bcf283840856fa458795315f8ead1ce13081f11547a5
84 rdf:type schema:PropertyValue
85 N0f2d1fc039224f5dbadc90aa429b4a32 schema:name doi
86 schema:value 10.1038/bmt.2014.9
87 rdf:type schema:PropertyValue
88 N1084cc8cb1fa43b6bf21540dab86b6f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Aged
90 rdf:type schema:DefinedTerm
91 N12098e38e7be4ba9b483ba5a688b7478 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Survival Analysis
93 rdf:type schema:DefinedTerm
94 N15a64546d9444081b49d83fc549869d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Predictive Value of Tests
96 rdf:type schema:DefinedTerm
97 N193150b30cab4fcb8640e4261773be00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Flow Cytometry
99 rdf:type schema:DefinedTerm
100 N1dcd9a3f474a4e69ac15a0a9795ece5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Young Adult
102 rdf:type schema:DefinedTerm
103 N25e7cfa86a934082a76b04e294f70899 rdf:first sg:person.01053700261.59
104 rdf:rest N262284586e5447be94021868464688cf
105 N262284586e5447be94021868464688cf rdf:first sg:person.016310433302.65
106 rdf:rest N97dac02b3d4b44e4874b89b37109c933
107 N26deaa7ac40f421391232d50497b64a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Neoplasm, Residual
109 rdf:type schema:DefinedTerm
110 N2be7220926414b8fb751e0d15a16c151 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Adolescent
112 rdf:type schema:DefinedTerm
113 N33c9bb4a1d1b4dadabe950b5d2aab22d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 N4964c0a51553463a884e4fa0584cc806 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Leukemia, Myeloid, Acute
118 rdf:type schema:DefinedTerm
119 N49e7e629963d4a13ae67019ba965db86 rdf:first sg:person.0631553145.39
120 rdf:rest N7d541befa084442383fc0c0116bec35d
121 N5680e6e766164bd8b794e5d544d22ef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Adult
123 rdf:type schema:DefinedTerm
124 N5fc336598bc24cfb984868be29b984e1 rdf:first sg:person.01353611054.53
125 rdf:rest N49e7e629963d4a13ae67019ba965db86
126 N6eb32afbb3c94ee6999a515e3b2d8916 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Myeloablative Agonists
128 rdf:type schema:DefinedTerm
129 N71b31573eb374789aba2d42c13b6a325 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Retrospective Studies
131 rdf:type schema:DefinedTerm
132 N7c5d93be7116448dab4f1916f5a38242 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Recurrence
134 rdf:type schema:DefinedTerm
135 N7d541befa084442383fc0c0116bec35d rdf:first sg:person.01010661144.85
136 rdf:rest Nd5651a2027da47e19dede6b4b9777d26
137 N97dac02b3d4b44e4874b89b37109c933 rdf:first sg:person.0727054455.03
138 rdf:rest rdf:nil
139 N99432cfa2ade480b8f9eece3863f710f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Middle Aged
141 rdf:type schema:DefinedTerm
142 Na7a840a2ba664f8b8140c99b25b803f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Hematopoietic Stem Cell Transplantation
144 rdf:type schema:DefinedTerm
145 Naaad1f5352c84642bd470e17681bede6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Multivariate Analysis
147 rdf:type schema:DefinedTerm
148 Nbc49eb18397446de856ba5a570a2d18a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Transplantation, Homologous
150 rdf:type schema:DefinedTerm
151 Nc2a723dff229452da27b764940d9c841 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Transplantation Conditioning
153 rdf:type schema:DefinedTerm
154 Nc83c9063112c454a9eaef0df8c3766ca schema:name nlm_unique_id
155 schema:value 8702459
156 rdf:type schema:PropertyValue
157 Nce8c661db47c4ee4b336b12f4a5527d6 schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 Nd5651a2027da47e19dede6b4b9777d26 rdf:first sg:person.01021756561.08
160 rdf:rest N25e7cfa86a934082a76b04e294f70899
161 Nd97093a55cee4dfe83d9b1235043eeec schema:volumeNumber 49
162 rdf:type schema:PublicationVolume
163 Ne1833f751c764474b72f1a50dc0910fe schema:name dimensions_id
164 schema:value pub.1021248967
165 rdf:type schema:PropertyValue
166 Nf1b324bd10c04f8f8bfb11274dc29c74 schema:name pubmed_id
167 schema:value 24510069
168 rdf:type schema:PropertyValue
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
173 schema:name Oncology and Carcinogenesis
174 rdf:type schema:DefinedTerm
175 sg:journal.1096890 schema:issn 0268-3369
176 1476-5365
177 schema:name Bone Marrow Transplantation
178 rdf:type schema:Periodical
179 sg:person.01010661144.85 schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
180 schema:familyName Morilla
181 schema:givenName R
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010661144.85
183 rdf:type schema:Person
184 sg:person.01021756561.08 schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
185 schema:familyName Morilla
186 schema:givenName A
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021756561.08
188 rdf:type schema:Person
189 sg:person.01053700261.59 schema:affiliation https://www.grid.ac/institutes/grid.424926.f
190 schema:familyName Ethell
191 schema:givenName M E
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053700261.59
193 rdf:type schema:Person
194 sg:person.01353611054.53 schema:affiliation https://www.grid.ac/institutes/grid.424926.f
195 schema:familyName Anthias
196 schema:givenName C
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353611054.53
198 rdf:type schema:Person
199 sg:person.016310433302.65 schema:affiliation https://www.grid.ac/institutes/grid.424926.f
200 schema:familyName Potter
201 schema:givenName M N
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016310433302.65
203 rdf:type schema:Person
204 sg:person.0631553145.39 schema:affiliation https://www.grid.ac/institutes/grid.424926.f
205 schema:familyName Dignan
206 schema:givenName F L
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631553145.39
208 rdf:type schema:Person
209 sg:person.0727054455.03 schema:affiliation https://www.grid.ac/institutes/grid.426412.7
210 schema:familyName Shaw
211 schema:givenName B E
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727054455.03
213 rdf:type schema:Person
214 sg:pub.10.1038/bmt.2013.124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027049780
215 https://doi.org/10.1038/bmt.2013.124
216 rdf:type schema:CreativeWork
217 sg:pub.10.1038/sj.leu.2404313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029511634
218 https://doi.org/10.1038/sj.leu.2404313
219 rdf:type schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1074731728 schema:CreativeWork
221 https://app.dimensions.ai/details/publication/pub.1075299915 schema:CreativeWork
222 https://app.dimensions.ai/details/publication/pub.1077254470 schema:CreativeWork
223 https://app.dimensions.ai/details/publication/pub.1083152211 schema:CreativeWork
224 https://doi.org/10.1001/jama.2009.813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022940233
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1002/ajh.21340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040068744
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.bbmt.2011.02.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021789580
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.beha.2007.11.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052238191
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.beha.2010.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007698899
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.leukres.2010.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012262959
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.leukres.2012.04.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008549363
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1056/nejmoa041974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020502159
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejmoa074306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013947506
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1182/blood-2002-12-3714 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052289115
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1182/blood-2003-03-0880 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038155124
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1182/blood-2004-03-1036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024111969
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1182/blood-2006-06-025627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022105086
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1182/blood-2006-09-047225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047732589
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1182/blood-2009-03-209262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038343487
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1182/blood-2009-11-254441 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021909700
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1182/blood-2011-08-363291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028166821
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1182/blood-2013-06-506725 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007787544
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1200/jco.2007.15.9814 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016398724
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1200/jco.2009.22.4865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008077664
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1200/jco.2010.31.8121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049240685
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1309/fy0umamm91vpmr2w schema:sameAs https://app.dimensions.ai/details/publication/pub.1042362593
267 rdf:type schema:CreativeWork
268 https://doi.org/10.3109/10428194.2010.500431 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037021077
269 rdf:type schema:CreativeWork
270 https://www.grid.ac/institutes/grid.18886.3f schema:alternateName Institute of Cancer Research
271 schema:name Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK
272 The Institute of Cancer Research, Sutton, UK
273 rdf:type schema:Organization
274 https://www.grid.ac/institutes/grid.424926.f schema:alternateName Royal Marsden Hospital
275 schema:name Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK
276 rdf:type schema:Organization
277 https://www.grid.ac/institutes/grid.426412.7 schema:alternateName Anthony Nolan
278 schema:name Anthony Nolan, UCL Cancer Centre, London, UK
279 Section of Haemato-oncology, The Royal Marsden Hospital, Sutton, UK
280 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...